jaxdog

$FFTY Forming a VCP (Volatility Contraction Pattern)?

Long
jaxdog Updated   
AMEX:FFTY   Innovator IBD 50 ETF
FFTY looks to me like it is working on a VCP with volatility shrinking and forming a nice wedging pattern. I like this pattern “IF” or when the market turns positive.

Here are the negative things I see, as of now it is trading below or right at the 18-month AVWAP. It is right at shorter term resistance. It is below the downward sloping wedge trendline. And the RS is still declining.

On the Positive side I see current price is about 11% below the 52-week high. Price is above all the moving averages including the 50 DMA and the 40 Week MA. Price is above the upward sloping wedge trendline.

Here is my trading plan, if the overall market looks good, RS breaks above the trendline and price moves above the 18-month AVWAP I will start with a one-third size position. My stop will be price closing below the 50 DMA. If it breaks out over the wedge downtrend line, I will make it a two-thirds sized position. If it can consolidate without stopping me out, I will build to a full position on any resumption of the uptrend. All TBD.

Ideas, not investing / trading advice. Comments always welcome. Thanks for looking.

FFTY The IBD 50 Innovator Fund is comprised of IBD’s picks for high growth stocks. The stocks represented turnover more often than most ETF’s.
Comment:
FFTY I have decided not to trade this ETF. The reason is that it only trades on average around 150k shares a day. I try and trade only stocks / ETFs that trade over 750k per day with some minor exceptions. I'll bee looking at the
ARKK ETF and may post something on that soon.

Ideas I publish are my own. They are not meant to be investment / trading advice. You are encouraged to do your own due diligence.

I may or may not take any trade published and I am under no obligation to post any action or update to any idea.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.